Intra-Operative Bioprinting of Hard, Soft, and Hard/Soft Composite Tissues for Craniomaxillofacial Reconstruction

Moncal K. K., Gudapati H., Godzik K. P., Heo D. N., Kang Y., Rizk E., ...Daha Fazla

ADVANCED FUNCTIONAL MATERIALS, cilt.31, sa.29, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 29
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1002/adfm.202010858
  • Dergi Adı: ADVANCED FUNCTIONAL MATERIALS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Aerospace Database, Applied Science & Technology Source, Chemical Abstracts Core, Chimica, Communication Abstracts, Compendex, INSPEC, Metadex, Civil Engineering Abstracts
  • Anahtar Kelimeler: bioinks, craniomaxillofacial reconstruction, hard, soft composite tissue bioprinting, intra&#8208, operative bioprinting, tissue engineering, BONE MORPHOGENETIC PROTEINS, STEM-CELLS, SKIN, REGENERATION, DEFECTS, SCAFFOLDS, DELIVERY, COLLAGEN, GROWTH, FIBROBLASTS
  • Çukurova Üniversitesi Adresli: Evet

Özet

Reconstruction of complex craniomaxillofacial (CMF) defects is challenging due to the highly organized layering of multiple tissue types. Such compartmentalization necessitates the precise and effective use of cells and other biologics to recapitulate the native tissue anatomy. In this study, intra-operative bioprinting (IOB) of different CMF tissues, including bone, skin, and composite (hard/soft) tissues, is demonstrated directly on rats in a surgical setting. A novel extrudable osteogenic hard tissue ink is introduced, which induced substantial bone regeneration, with approximate to 80% bone coverage area of calvarial defects in 6 weeks. Using droplet-based bioprinting, the soft tissue ink accelerated the reconstruction of full-thickness skin defects and facilitated up to 60% wound closure in 6 days. Most importantly, the use of a hybrid IOB approach is unveiled to reconstitute hard/soft composite tissues in a stratified arrangement with controlled spatial bioink deposition conforming the shape of a new composite defect model, which resulted in approximate to 80% skin wound closure in 10 days and 50% bone coverage area at Week 6. The presented approach will be absolutely unique in the clinical realm of CMF defects and will have a significant impact on translating bioprinting technologies into the clinic in the future.